Author:
Van Der Rijt C. C. D.,Splinter T. A. W.
Publisher
Springer Berlin Heidelberg
Reference62 articles.
1. Babaian RJ, Johnson DE, Llamas L, Ayala AG (1980) Metastases from transitional cell carcinoma of urinary bladder. Urology 16: 142–144
2. Bellmunt J, Albanell J, Gallego OS, et al. (1992) Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapy. Cancer 70: 1974–1979
3. Bellmunt J, Ribas A, Bermejo B, et al. (1996) M-VAC versus M-CAVI (methotrexate, carboplatin, vinblastine) in advanced surgically incurable bladder cancer. Proc Am Soc Clin Oncol 15: 265
4. Boutan-Laroze A, Mahjoubi M, Droz JP, et al. (1991) M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. The French Federation of Cancer Centers Experience. Eur J Cancer 27: 1690–1694
5. Carmichael J, Cornbleet MA, MacDougall RH, Allan SG, Duncan W, Chisholm GD, Smyth JF (1985) Cis-platin and methotrexate in the treatment of transitional cell carcinoma of the urinary tract. Br J Urol 57: 299–302